BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PSA AND Diagnosis
26 results:

  • 1. brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
    Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
    Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.
    Mahmoud AM; Childs DS; Ahmed ME; Tuba Kendi A; Johnson GB; Orme JJ; Stish BJ; Phillips RM; Park SS; Davis BJ; Andrews JR; Kwon ED
    Prostate; 2024 Feb; 84(3):237-244. PubMed ID: 37899635
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate cancer.
    Hamdy FC; Donovan JL; Lane JA; Metcalfe C; Davis M; Turner EL; Martin RM; Young GJ; Walsh EI; Bryant RJ; Bollina P; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Rosario DJ; Rowe E; Mason M; Catto JWF; Peters TJ; Oxley J; Williams NJ; Staffurth J; Neal DE;
    N Engl J Med; 2023 Apr; 388(17):1547-1558. PubMed ID: 36912538
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate cancer.
    Pobel C; Laurent E; Florence AM; Fromont G; Calais G; Narciso B; Linassier C; Cancel M
    Clin Genitourin Cancer; 2022 Oct; 20(5):495.e1-495.e9. PubMed ID: 35562276
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prostate cancer Metastasis to the Pituitary Gland Manifesting as Corticosteroid Withdrawal, and the Impact of the Switch from Prednisone to Dexamethasone on Survival Time.
    Ataikiru O; Abdelsalam M; Avileli M; Hynes T
    Curr Oncol; 2021 Oct; 28(6):4291-4297. PubMed ID: 34898537
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
    Graham LS; Montgomery B; Cheng HH; Yu EY; Nelson PS; Pritchard C; Erickson S; Alva A; Schweizer MT
    PLoS One; 2020; 15(5):e0233260. PubMed ID: 32453797
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer.
    Wang J; Xu W; Mierxiati A; Huang Y; Wei Y; Lin G; Dai B; Freedland SJ; Qin X; Zhu Y; Ye DW
    Prostate; 2019 Sep; 79(13):1563-1571. PubMed ID: 31376193
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Implication of Tests for Prostate-specific Antigen in brain-dead Organ Donors.
    Lee GW; Lee JM; Lee WJ; Kim YB; Min YG
    Transplant Proc; 2018; 50(1):20-23. PubMed ID: 29407309
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metastatic Adenocarcinoma of the Prostate Diagnosed in a Colon Polyp: A Unique Clinicopathologic Scenario.
    Tjarks BJ; Muirhead D
    S D Med; 2016 Jul; 69(7):309-311. PubMed ID: 28806019
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate cancer.
    Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Kockelbergh R; Kynaston H; Paul A; Powell P; Prescott S; Rosario DJ; Rowe E; Neal DE;
    N Engl J Med; 2016 Oct; 375(15):1415-1424. PubMed ID: 27626136
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A Case of Difficult-to-Diagnose Carcinomatous Meningitis Caused by Prostate cancer Metastasis].
    Shinohara M; Kiba K; Yamada A; Hatakeyama K; Mita Y; Saka T; Hirao Y
    Hinyokika Kiyo; 2016 May; 62(5):265-9. PubMed ID: 27320119
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer.
    Takayama T; Kubo T; Morikawa A; Morita T; Nagano O; Saya H
    Med Oncol; 2016 May; 33(5):45. PubMed ID: 27044355
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. If you have an active vagus nerve, cancer stage may no longer be important.
    Gidron Y; De Couck M; De Greve J
    J Biol Regul Homeost Agents; 2014; 28(2):195-201. PubMed ID: 25001652
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metastasizing "benign" pleomorphic salivary adenoma: a dramatic case-report and literature review.
    Tarsitano A; Foschini MP; Farneti P; Pasquini E; Marchetti C
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1562-5. PubMed ID: 24507933
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Visual loss from a pituitary mass: collision tumors of prostatic metastasis and suprasellar meningioma.
    Lim AC; Cerra C; Pal P; Kearney T; Gnanalingham KK
    J Neurol Surg A Cent Eur Neurosurg; 2013 Dec; 74 Suppl 1():e81-4. PubMed ID: 22847068
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Psychological distress and prostate specific antigen levels in men with and without prostate cancer.
    Turner EL; Lane JA; Metcalfe C; Down L; Donovan JL; Hamdy F; Neal D; Vedhara K
    Brain Behav Immun; 2009 Nov; 23(8):1073-8. PubMed ID: 19486654
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Metastases in the paranasal sinuses secondary to prostatic adenocarcinoma].
    Llarena Ibarguren R; García-Olaverri Rodríguez J; Villafruela Mateos A; Azurmendi Arin I; Olano Grasa I; Pertusa Peña C
    Arch Esp Urol; 2007 Nov; 60(9):1.137-40. PubMed ID: 18077874
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The role of P501S and psa in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Orbital metastasis of prostatic carcinoma].
    El Mejjad A; Jouhadi H; Fekak H; Rabii R; Bennani S; Benider A; El Mrini M
    Prog Urol; 2005 Feb; 15(1):85-8. PubMed ID: 15822401
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.